Astrana Health (ASTH) Change in Receivables (2010 - 2025)

Astrana Health has reported Change in Receivables for 16 years, with the latest figure at $10.4 million in Q1 2025.

• Quarterly Change in Receivables fell 60.32% year-over-year to $10.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $20.0 million (down 1.56% YoY) and the FY2025 annual result came in at $9.4 million, down 73.65% from the prior year.
• Change in Receivables advanced to $10.4 million in Q1 2025 per ASTH's latest filing, from -$2.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $44.7 million in Q1 2022 and troughed at -$25.7 million in Q4 2023.
• A 5-year average of $6.3 million and a median of $2.1 million in 2022 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2022 and 2023: Change in Receivables soared 1870.77% in 2022, then slumped 178.73% in 2023.
• Over 5 years, Change in Receivables stood at -$9.2 million in 2021, then sank by 119.58% to -$20.1 million in 2022, then dropped by 27.63% to -$25.7 million in 2023, then surged by 91.59% to -$2.2 million in 2024, then surged by 579.56% to $10.4 million in 2025.
• According to Business Quant data, Change in Receivables over the past three periods registered $10.4 million, -$2.2 million, and -$85000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.